MeSH term
Frequency | Condition_Probility | Humans | 45 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Comet Assay | 3 | 4.0 |
Dose-Response Relationship, Drug | 10 | 0.0 |
Micronucleus Tests | 5 | 10.0 |
Research Support, Non-U.S. Gov't | 21 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Kinetics | 3 | 0.0 |
*Mutagens | 11 | 33.0 |
Time Factors | 3 | 0.0 |
Adult | 6 | 0.0 |
Animals | 31 | 0.0 |
Aroclors/pharmacology | 3 | 60.0 |
Cells, Cultured | 8 | 0.0 |
Lymphocytes/drug effects | 4 | 5.0 |
Male | 13 | 0.0 |
Mutagenicity Tests/*methods | 4 | 15.0 |
Rats | 18 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Sister Chromatid Exchange/drug effects | 5 | 26.0 |
Comparative Study | 10 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Cattle | 2 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Mutagenicity Tests | 15 | 9.0 |
Amino Acid Sequence | 4 | 0.0 |
Base Sequence | 5 | 0.0 |
Mice | 10 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Cell Line | 8 | 0.0 |
*Chromosome Aberrations | 4 | 0.0 |
DNA Damage | 2 | 0.0 |
Hamsters | 9 | 0.0 |
In Vitro | 3 | 0.0 |
Microsomes, Liver/metabolism | 9 | 5.0 |
*DNA Damage | 2 | 0.0 |
Female | 11 | 0.0 |
Middle Aged | 3 | 0.0 |
Mutation | 3 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Biotransformation | 18 | 3.0 |
Mutagens/*metabolism | 2 | 5.0 |
Plasmids | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cricetulus | 5 | 1.0 |
Fibroblasts/*drug effects | 2 | 10.0 |
Lung | 2 | 2.0 |
Lymphocytes/*drug effects | 2 | 4.0 |
DNA Primers | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Salmonella typhimurium/drug effects | 8 | 44.0 |
Sister Chromatid Exchange/*drug effects | 3 | 10.0 |
Liver/metabolism | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
*X Chromosome | 2 | 0.0 |
Benzidines/*toxicity | 2 | 40.0 |
Lymphoma | 2 | 5.0 |
Microsomes, Liver/drug effects/*metabolism | 2 | 5.0 |
Liver/*metabolism | 3 | 0.0 |
Rats, Inbred Strains | 4 | 0.0 |
DNA Replication/drug effects | 2 | 1.0 |
Chromosome Aberrations | 3 | 0.0 |
Cyclophosphamide/metabolism/pharmacology | 2 | 50.0 |
9,10-Dimethyl-1,2-benzanthracene/metabolism/*pharmacology | 2 | 100.0 |
DNA/genetics | 2 | 0.0 |
Adolescent | 2 | 0.0 |
*Mutation | 3 | 0.0 |
Microsomes, Liver/*metabolism | 2 | 1.0 |
Species Specificity | 3 | 0.0 |
Mutation/*drug effects | 2 | 11.0 |
Structure-Activity Relationship | 2 | 0.0 |
*Biotransformation | 2 | 50.0 |
*Crossing Over, Genetic | 2 | 6.0 |
*Sister Chromatid Exchange | 2 | 6.0 |
Genetic Techniques | 2 | 2.0 |
